Systemic lupus erythematosus (SLE)

Arthritis and Rheumatism, vol. 32, No. 9 (September 1989)

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
Matthew H. Liang, Steven A. Socher, Martin G. Larson, Peter H. Schur

Arthritis and Rheumatism, vol. 50, No. 11 (November 2004)

Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus
Ad Hoc Working Group on Steroid-Sparing Criteria in Lupus

J Autoimmun. 1998 Oct;11(5):495-501.

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok A, Domschke W, Schneider M.

Ther Apher Dial. 2006 Apr;10(2):187-92.

Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.
Sugimoto K, Yamaji K, Yang KS, Kanai Y, Tsuda H, Hashimoto H.

Ther Apher Dial. 2008 Aug;12(4):298-305.

Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
Yamaji K, Kim YJ, Tsuda H, Takasaki Y.

Rheumatoid arthritis (RA)

Ther Apher Dial. 2004 Oct;8(5):404-8.

Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein.
Matsuda Y, Tsuda H, Takasaki Y, Hashimoto H

Ther Apher. 2000 Jun;4(3):211-2.

Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
Sueoka A.

Jpn J Apheresis 1997;16(1):189-190

Randomized Open Trial to Compare the Effectiveness of Cryofiltration and Leukapheresis in Methotrexate-Resistant RA patients
Inoh M, Tokuda M, Akashi Y, Seto K, Kurita N, Takehara J

J Clin Rheumatol. 2007 Aug;13(4):193-8.

A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X, Ma J, Tian J, Jiang S, Xu P, Han H, Wang L.

Familial hypercholesterolemia

Int J Artif Organs. 2002 Dec;25(12):1180-8.

Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
Julius U, Metzler W, Pietzsch J, Fassbender T, Klingel R.

Ther Apher Dial. 2003 Jun;7(3):350-8.

From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
Klingel R, Fassbender T, Fassbender C, Gohlen B.

Therapeutic Apheresis, 2000 3(3):199-202

Low density lipoprotein apheresis by membrane differential filtration (Cascade filtration)
Hans C. Geiss, K.G. Parhofer, M. G. Donner, and P. Schwandt

Transfusion and Apheresis Science, 2004, 30, 245-254

Lipidfiltration - safe and effective methodology to perform lipid-apheresis
Klingel R, Mausfeld P, Fassbender C, Gohlen B.

J Clin Apher. 2007;22(4):215-23.

Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
Julius U, Parhofer KG, Heibges A, Kurz S, Klingel R, Geiss HC.

Ther Apher Dial. 2010 Oct;14(5):484-5.

Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
Fernández-Fuertes LF, Tapia Martín M, Nieves Plá I, Novoa Mogollón FJ, Díaz Cremades J.

Myasthenia gravis (MG)

Artif Cells Blood Substit Immobil Biotechnol. 2003 Feb;31(1):69-79.

Plasmaperfusion on triptophan columns can improve the clinical outcome of patients affected with myasthenia gravis.
Splendiani G, Cipriani S, Passalacqua S, Sturniolo A, Costanzi S, Fulignati P, Staffolani E, Casciani CU.

J Clin Apher. 2003;18(3):125-8.

Pulmonary function study of myasthenia-gravis patients treated with double filtration plasmapheresis.
Chiu HC, Yeh JH, Chen WH.

Dtsch Med Wochenschr. 2008 Nov;133(46):2377-82. German.

[Long-term treatment of refractory myasthenia gravis with immunoadsorption]
Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R, Grützmacher PW.

Eur Neurol. 2011;65(1):16-22.

Early aggressive treatment strategy against myasthenia gravis.
Nagane Y, Suzuki S, Suzuki N, Utsugisawa K.

Guillain-Barré syndrome (GBS)

Ther Apher. 2000 Jun;4(3):198-200.

Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome.
Haupt WF, Birkmann C, van der Ven C, Pawlik G.

Ther Apher Dial. 2004 Jun;8(3):248-53.

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome.
Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.

Clin Neurol Neurosurg. 2005 Oct;107(6):491-6.

Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
Seta T, Nagayama H, Katsura K, Hamamoto M, Araki T, Yokochi M, Utsumi K, Katayama Y.

Brain Dev. 2005 Sep;27(6):431-3.

Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
Arakawa H, Yuhara Y, Todokoro M, Kato M, Mochizuki H, Tokuyama K, Kunimoto F, Morikawa A.

Chronic inflammatory demyelinating polyneuropathy (CIDP)

Ther Apher. 2000 Jun;4(3):229-34.

Neutrophil activation in immunoadsorption.
Ota K, Shimizu Y, Ichikawa H, Ueda M, Akiyama N, Higuchi C, Agishi T, Iwata M.

Multiple sclerosis (MS)

Neurology. 2001 Jun 12;56(11):1514-22.

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis.
Noseworthy JH, O'Brien PC, Petterson TM, Weis J, Stevens L, Peterson WK, Sneve D, Cross SA, Leavitt JA, Auger RG, Weinshenker BG, Dodick DW, Wingerchuk DM, Rodriguez M.

Ther Apher Dial. 2008 Jun;12(3):250-4.

A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A, De Robertis F, Brescia P, Saliani MT, Amoruso M, Prontera M, Dimonte E, Trojano M, Coratelli P.